Azoospermic HIV-1 infected patients wishing to have children: proposed strategy to reduce HIV-1 transmission risk during sperm retrieval and intracytoplasmic sperm injection: Case Report.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 17640946)

Published in Hum Reprod on July 19, 2007

Authors

Louis Bujan1, Myriam Daudin, Nathalie Moinard, Pierre Plante, Jean Parinaud, Christophe Pasquier

Author Affiliations

1: Université Toulouse III Paul Sabatier, Research Group on Human Fertility, EA 3694, Toulouse, France. bujan.l@chu-toulouse.fr

Articles by these authors

Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol (2005) 2.68

Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother (2002) 2.11

MicroRNAs in gene regulation: when the smallest governs it all. J Biomed Biotechnol (2006) 1.76

Testicular cancer variations in time and space in Europe. Eur Urol (2006) 1.67

Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network. Fertil Steril (2013) 1.59

Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest (2011) 1.49

[Partial nephrectomy by selective renal parenchymal clamping using a new clamp]. Prog Urol (2007) 1.45

A computerized decision support system for ovarian stimulation by gonadotropins. Fertil Steril (2002) 1.44

Impact of diagnostic delay in testis cancer: results of a large population-based study. Eur Urol (2007) 1.44

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy. PLoS One (2009) 1.42

Mild induced testicular and epididymal hyperthermia alters sperm chromatin integrity in men. Fertil Steril (2012) 1.42

[Efficacy and safety of Pelvicol in the vaginal treatment of prolapse]. Prog Urol (2006) 1.42

Retroperitoneoscopic adrenalectomy: comparison of retrograde and antegrade approach among a series of 279 cases. Urology (2013) 1.40

Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies. J Clin Microbiol (2007) 1.39

Conservative management of small testicular tumors relative to carcinoma in situ prevalence. J Urol (2005) 1.39

R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 1.37

New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol (2007) 1.34

Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol (2006) 1.30

Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism. J Clin Microbiol (2009) 1.30

Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses. J Acquir Immune Defic Syndr (2010) 1.24

Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS (2004) 1.22

Polyorchidism: presentation of 2 cases, review of the literature and a new management strategy. Urol Int (2008) 1.20

Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype. J Infect Dis (2002) 1.20

The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960. Infect Genet Evol (2006) 1.19

Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART. AIDS (2005) 1.19

Hepatitis C virus infection in cameroon: A cohort-effect. J Med Virol (2005) 1.18

Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes. J Med Virol (2003) 1.09

High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol (2003) 1.06

Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression. Virology (2002) 1.06

Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol (2005) 1.05

Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy. J Virol (2006) 1.05

Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy. J Clin Microbiol (2009) 1.04

No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients. Transpl Int (2009) 0.99

Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg (2005) 0.99

A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol (2002) 0.97

Genotypic prediction of HIV-1 CRF01-AE tropism. J Clin Microbiol (2012) 0.97

Cytogenetic investigations of infertile men with low sperm counts: a 25-year experience. J Androl (2002) 0.96

Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview. Transpl Int (2007) 0.96

Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia. J Med Virol (2003) 0.95

Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol (2005) 0.94

Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucose. Eur J Nucl Med Mol Imaging (2011) 0.93

Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV. J Med Virol (2003) 0.92

Genetic diversity of HCV genotype 2 strains in south western France. J Med Virol (2007) 0.90

High risk of temporary alteration of semen parameters after recent acute febrile illness. Fertil Steril (2007) 0.89

Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion. Eur Urol (2004) 0.89

Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV. J Med Virol (2008) 0.88

Fertility after testicular cancer treatments: results of a large multicenter study. Cancer (2004) 0.88

The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network. J Androl (2012) 0.87

Genetic heterogeneity of the NS5A gene of hepatitis C virus and early response to interferon-alpha. J Infect Dis (2003) 0.87

Insemination with isolated and virologically tested spermatozoa is a safe way for human immunodeficiency type 1 virus-serodiscordant couples with an infected male partner to have a child. Fertil Steril (2004) 0.86

Full-length genome sequences of hepatitis C virus subtype 4f. J Gen Virol (2007) 0.86

Decreased semen volume and spermatozoa motility in HIV-1-infected patients under antiretroviral treatment. J Androl (2007) 0.85

Determining the source of nosocomial transmission in hemodialysis units in Tunisia by sequencing NS5B and E2 sequences of HCV. J Med Virol (2007) 0.84

Validation of an automated real-time PCR protocol for detection and quantitation of HIV and HCV genomes in semen. J Virol Methods (2006) 0.84

Cumulative parenthood rates in 1735 couples: impact of male factor infertility. Hum Reprod (2012) 0.83

Erectile dysfunction in end-stage liver disease men. J Sex Med (2009) 0.82

Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha. J Med Virol (2002) 0.82

Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2009) 0.82

Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract. AIDS (2008) 0.82

Good efficiency of intrauterine insemination programme for serodiscordant couples with HIV-1 infected male partner: a retrospective comparative study. Eur J Obstet Gynecol Reprod Biol (2007) 0.81

Open partial nephrectomy with selective renal parenchymal control: a new reliable clamp. Urology (2006) 0.81

Involvement of Dcr1 in post-transcriptional regulation of gene expression in Schizosaccharomyces pombe. Front Biosci (2008) 0.81

Multicenter quality control for the detection of hepatitis C virus RNA in seminal plasma specimens. J Clin Microbiol (2003) 0.81

Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts. AIDS Res Hum Retroviruses (2006) 0.81

[Retroperitoneal laparoscopic surgery for phaeochromocytoma: analysis of morbidity and haemodynamic instability]. Prog Urol (2007) 0.81

[Treatment of bladder outlet obstruction secondary to suburethral tape by section of the tape]. Prog Urol (2006) 0.80

Decrease of mitochondrial DNA level in sperm from patients infected with human immunodeficiency virus-1 linked to nucleoside analogue reverse transcriptase inhibitors. Fertil Steril (2010) 0.80

Midodrine improves orgasm in spinal cord-injured men: the effects of autonomic stimulation. J Sex Med (2008) 0.80

Ten-year variation in semen parameters and sperm deoxyribonucleic acid integrity in a healthy fertile man. Fertil Steril (2006) 0.79

Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C. J Med Virol (2008) 0.79

Ribavirin and pegylated interferon treatment for hepatitis C was associated not only with semen alterations but also with sperm deoxyribonucleic acid fragmentation in humans. Fertil Steril (2008) 0.78

Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre study. Reprod Biomed Online (2009) 0.78

Decrease of Lewis frequency in HIV-infected patients: possible competition of fucosylated antigens with HIV for binding to DC-SIGN. AIDS (2005) 0.78

Assessment of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences. J Virol Methods (2003) 0.78

Synchronous epidermoid cyst and mature teratoma of the testis: an unusual association. Urol Int (2007) 0.78

Antiviral effect of maraviroc in semen: a case report. Antivir Ther (2012) 0.77

Soluble HLA-G and embryo implantation: frequently asked questions. Gynecol Obstet Invest (2007) 0.77

Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients. J Urol (2009) 0.77

Clinical and biological parameters influencing implantation: score to determine number of embryos to transfer. Reprod Biomed Online (2006) 0.76

A cost-effective algorithm for the diagnosis of Hepatitis C virus infection and prediction of HCV viremia in Cameroon. J Virol Methods (2005) 0.76

Treatment discontinuation in couples consulting for male infertility after failing to conceive. Fertil Steril (2012) 0.76

Sperm vacuoles are not modified by freezing--thawing procedures. Reprod Biomed Online (2012) 0.76

Choice of ART programme for serodiscordant couples with an HIV infected male partner. Hum Reprod (2006) 0.75

Trying to avoid the transmission of human immunodeficiency virus particles in sperm ejaculates. Fertil Steril (2007) 0.75